Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 4:28 AM
Ignite Modification Date:
2025-12-26 @ 3:31 AM
NCT ID:
NCT00686920
Group ID:
EG001
Title:
Continuing Rifaximin
Description:
Participants who received rifaximin in the previous rifaximin HE study were administered a single rifaximin 550 milligram (mg) tablet 2 times per day (approximately every 12 hours) for at least 24 months, until regulatory approval of rifaximin for reduction in risk of overt HE recurrence, or until the sponsor closed the study.
Deaths Number Affected:
None
Deaths Number At Risk:
None
Serious Number Affected:
49
Serious Number At Risk:
70
Other Number Affected:
52
Other Number At Risk:
70
Study:
NCT00686920
Results Section:
NCT00686920
Adverse Events Module:
NCT00686920